Nuveen Asset Management, LLC Kezar Life Sciences, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.15 $861 - $1,376	1,197 Added 0.38%	314,762 $299,000
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $1,707 - $4,015	-1,581 Reduced 0.5%	313,565 $373,000
Q2 2023 Aug 14, 2023	SELL	$2.31 - $3.06 $545,601 - $722,744	-236,191 Reduced 42.84%	315,146 $772,000
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $2.21 Million - $5.16 Million	-705,951 Reduced 56.15%	551,337 $1.73 Million
Q4 2022 Feb 14, 2023	SELL	$6.39 - $8.8 $766,857 - $1.06 Million	-120,009 Reduced 8.71%	1,257,288 $8.85 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $6.4 Million - $8.61 Million	800,540 Added 138.8%	1,377,297 $11.9 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $1.99 Million - $7.44 Million	434,234 Added 304.68%	576,757 $4.77 Million
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $448,863 - $668,916	-36,493 Reduced 20.39%	142,523 $2.11 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $41,768 - $93,866	5,614 Added 3.24%	179,016 $2.18 Million
Q3 2021 Nov 12, 2021	SELL	$4.85 - $9.73 $18,284 - $36,682	-3,770 Reduced 2.13%	173,402 $1.69 Million
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.46 $10,619 - $13,914	2,154 Added 1.23%	177,172 $962,000
Q1 2021 May 17, 2021	BUY	$5.24 - $6.99 $49,072 - $65,461	9,365 Added 5.65%	175,018 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$4.77 - $6.58 $5,189 - $7,159	-1,088 Reduced 0.65%	165,653 $865,000
Q3 2020 Nov 16, 2020	BUY	$4.36 - $5.5 $147,049 - $185,498	33,727 Added 25.36%	166,741 $807,000
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $78,235 - $168,423	21,732 Added 19.53%	133,014 $689,000
Q1 2020 May 14, 2020	BUY	$2.77 - $5.75 $194,919 - $404,616	70,368 Added 171.99%	111,282 $485,000
Q4 2019 Feb 14, 2020	SELL	$2.5 - $4.26 $50,312 - $85,732	-20,125 Reduced 32.97%	40,914 $164,000
Q3 2019 Nov 14, 2019	BUY	$3.0 - $7.58 $48,618 - $122,841	16,206 Added 36.15%	61,039 $200,000
Q2 2019 Aug 15, 2019	BUY	$7.09 - $21.9 $317,865 - $981,842	44,833 New	44,833 $346,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$46.7 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$32.8 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$23.7 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$17.9 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$16.4 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account